FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912377312> ?p ?o ?g. }

• W2912377312 endingPage "85" @default.
• W2912377312 startingPage "74" @default.
• W2912377312 abstract "Purpose: Investigating the triple effect of doxorubicin, 5-fluorouracil, propranolol on MCF-7 (ER+, WTp53) breast cancer cell line with MTT test and survival analysis. Materials/Methods: In order to determine effective dosages of a combination of doxorubicin, 5-fluorouracil, propranolol on the MCF-7 cell line by using MTT and survival analysis technique. Result: IC50 values acquired by MTT tests are 0.01 mg/ml for doxorubicin, 6 mg/ml for 5-fluorouracil, 30 mg/ml for propranolol and 0.2/1/30 mg/ml (with previous respect) if all three agents are combined. It is found that the use of doxorubicin, 5-fluorouracil, and propranolol in combination is much effective than their single application. Discussion: Moderate concentrations of doxorubicin, 5-fluorouracil, and propranolol, if they are applied individually, showed high toxicity. When we used these drugs in combination; toxic effects lessened with respect to monotherapy. In the MCF-7 cell line, doxorubicin (IC50: 0.01 μM) increases cell death rates significantly and propranolol (IC50: 3 μM) has minimum effects in monotherapy in contrast to others. Propranolol is only superior to itself in combination therapy (IC50: 4 μM). However 5-fluorouracil (IC50: 30 μM) showed antagonistic effects with respect to other drugs. Additionally, having applied the three drugs in combination on the MCF-7 cell line for the first time in literature, it is highly possible to assess the application of doxorubicin, 5-fluorouracil and propranolol combination as a novel therapy option." @default.
• W2912377312 created "2019-02-21" @default.
• W2912377312 creator A5028982308 @default.
• W2912377312 creator A5034266405 @default.
• W2912377312 creator A5068496681 @default.
• W2912377312 creator A5071499398 @default.
• W2912377312 creator A5071639078 @default.
• W2912377312 creator A5080555750 @default.
• W2912377312 date "2019-01-01" @default.
• W2912377312 modified "2023-09-25" @default.
• W2912377312 title "Triple Effect of Doxorubicin, 5-Fluorouracil, Propranolol on Cell Survival on MCF-7 Breast Cancer Cell Line" @default.
• W2912377312 cites W1509291382 @default.
• W2912377312 cites W1543790510 @default.
• W2912377312 cites W1977622321 @default.
• W2912377312 cites W1984328540 @default.
• W2912377312 cites W1997385587 @default.
• W2912377312 cites W2018652769 @default.
• W2912377312 cites W2062941476 @default.
• W2912377312 cites W2068577449 @default.
• W2912377312 cites W2068694673 @default.
• W2912377312 cites W2082976830 @default.
• W2912377312 cites W2086034451 @default.
• W2912377312 cites W2090077875 @default.
• W2912377312 cites W2091458141 @default.
• W2912377312 cites W2103885797 @default.
• W2912377312 cites W2107567947 @default.
• W2912377312 cites W2108155748 @default.
• W2912377312 cites W2114865501 @default.
• W2912377312 cites W2121258392 @default.
• W2912377312 cites W2151356556 @default.
• W2912377312 cites W2161761604 @default.
• W2912377312 cites W2169054045 @default.
• W2912377312 cites W2171892107 @default.
• W2912377312 cites W2317055602 @default.
• W2912377312 cites W2530867754 @default.
• W2912377312 cites W2586749137 @default.
• W2912377312 cites W2756562465 @default.
• W2912377312 cites W4210673819 @default.
• W2912377312 cites W4235030271 @default.
• W2912377312 cites W4323254161 @default.
• W2912377312 doi "https://doi.org/10.4236/jbm.2019.72007" @default.
• W2912377312 hasPublicationYear "2019" @default.
• W2912377312 type Work @default.
• W2912377312 sameAs 2912377312 @default.
• W2912377312 citedByCount "3" @default.
• W2912377312 countsByYear W29123773122020 @default.
• W2912377312 countsByYear W29123773122022 @default.
• W2912377312 crossrefType "journal-article" @default.
• W2912377312 hasAuthorship W2912377312A5028982308 @default.
• W2912377312 hasAuthorship W2912377312A5034266405 @default.
• W2912377312 hasAuthorship W2912377312A5068496681 @default.
• W2912377312 hasAuthorship W2912377312A5071499398 @default.
• W2912377312 hasAuthorship W2912377312A5071639078 @default.
• W2912377312 hasAuthorship W2912377312A5080555750 @default.
• W2912377312 hasBestOaLocation W29123773121 @default.
• W2912377312 hasConcept C109541995 @default.
• W2912377312 hasConcept C121608353 @default.
• W2912377312 hasConcept C126322002 @default.
• W2912377312 hasConcept C1491633281 @default.
• W2912377312 hasConcept C185592680 @default.
• W2912377312 hasConcept C202751555 @default.
• W2912377312 hasConcept C2776694085 @default.
• W2912377312 hasConcept C2777752497 @default.
• W2912377312 hasConcept C2778151854 @default.
• W2912377312 hasConcept C2780456651 @default.
• W2912377312 hasConcept C2780783641 @default.
• W2912377312 hasConcept C2781303535 @default.
• W2912377312 hasConcept C2994423619 @default.
• W2912377312 hasConcept C530470458 @default.
• W2912377312 hasConcept C55493867 @default.
• W2912377312 hasConcept C71924100 @default.
• W2912377312 hasConcept C98274493 @default.
• W2912377312 hasConceptScore W2912377312C109541995 @default.
• W2912377312 hasConceptScore W2912377312C121608353 @default.
• W2912377312 hasConceptScore W2912377312C126322002 @default.
• W2912377312 hasConceptScore W2912377312C1491633281 @default.
• W2912377312 hasConceptScore W2912377312C185592680 @default.
• W2912377312 hasConceptScore W2912377312C202751555 @default.
• W2912377312 hasConceptScore W2912377312C2776694085 @default.
• W2912377312 hasConceptScore W2912377312C2777752497 @default.
• W2912377312 hasConceptScore W2912377312C2778151854 @default.
• W2912377312 hasConceptScore W2912377312C2780456651 @default.
• W2912377312 hasConceptScore W2912377312C2780783641 @default.
• W2912377312 hasConceptScore W2912377312C2781303535 @default.
• W2912377312 hasConceptScore W2912377312C2994423619 @default.
• W2912377312 hasConceptScore W2912377312C530470458 @default.
• W2912377312 hasConceptScore W2912377312C55493867 @default.
• W2912377312 hasConceptScore W2912377312C71924100 @default.
• W2912377312 hasConceptScore W2912377312C98274493 @default.
• W2912377312 hasIssue "02" @default.
• W2912377312 hasLocation W29123773121 @default.
• W2912377312 hasOpenAccess W2912377312 @default.
• W2912377312 hasPrimaryLocation W29123773121 @default.
• W2912377312 hasRelatedWork W1982577921 @default.
• W2912377312 hasRelatedWork W2357290434 @default.
• W2912377312 hasRelatedWork W2794014465 @default.
• W2912377312 hasRelatedWork W2906337770 @default.
• W2912377312 hasRelatedWork W2912377312 @default.

• next